We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
General advice on vigilance - electronic cigarettes devices and refill containers.
MHRA scientific and regulatory advice for COVID-19 vaccine developers
Guidance for manufacturers of IVC filters. It outlines specific scenarios that should be considered when determining if an incident is reportable.
We can provide access to world-class regulatory knowledge, expertise and experience from within the MHRA.
Submitting notifications on the European common entry gate for Northern Ireland for suppliers of e-cigarettes and e-liquids.
Acceptable naming, presentation and packaging of nicotine-containing electronic cigarettes and refill containers.
How to report adverse incidents involving cardiac ablation devices under the vigilance system.
Report showing opportunities and challenges for community pharmacy teams to further support the public’s health.
To celebrate International Women’s Day 2023, some of our colleagues have shared their passion for STEM.
£500k is available to fund the development of novel PoC diagnostics devices.
Types of ingredients permitted in nicotine-containing liquids in electronic cigarettes and refill containers.
Sets out the payment due from members of the voluntary scheme for branded medicines pricing and access in 2020.
To share a common understanding of the objectives and the operations of the Access Consortium - Generic Medicines Working Group (GMWG).
Briefing for local authorities on the increasing role of community pharmacy in public health, working with councils and other community partners.
Access Consortium Statement on Good Manufacturing Practice (GMP) Inspections Reliance and Recognition
The UK Good Laboratory Practice Monitoring Authority (UK GLPMA) recognises that there are potential challenges COVID-19 will present to members of the GLP monitoring programme.
Update about the developing role of biosimilar medicines in the NHS in England and the safe, effective and consistent use of biosimilar medicines.
A unique initiative which aims to accelerate the time to patient care for transformative medicines and medicine-device combinations.
Information for pharmaceutical wholesalers explaining the main changes the Windsor Framework introduces to the packaging for all medicines licensed in the UK, effective from 1 January 2025.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).